Peoples Bancorp of North Carolina vs Peoples Bancorp
PEBK and PEBO side by side, both in commercial banks. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How PEBK and PEBO compare
Peoples Bancorp is the larger company, worth 6.0 times as much as Peoples Bancorp of North Carolina ($1.4B against $231M).
On earnings, Peoples Bancorp is cheaper: it trades at 11.3× trailing earnings, against 11.6× for Peoples Bancorp of North Carolina.
Both pay dividends: Peoples Bancorp of North Carolina yields 2.4% and Peoples Bancorp 4.4%.
Peoples Bancorp scores higher on the StockData Score (15 against 10 for Peoples Bancorp of North Carolina), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | PEBK | PEBO |
|---|---|---|
| Size and price | ||
| Market cap | $231M | $1.4B |
| Share price | $42.26 | $38.22 |
| Change, 1 year | 36.9% | 32.3% |
| Change, 5 years | 48.3% | 21.8% |
| Beta (5Y) | 0.35 | 0.01 |
| Employees | 268 | 1,454 |
| StockData Score | ||
| Total score | 10 | 15 (better) |
| Valuation score | 1 | 2 (better) |
| Growth score | 1 (better) | 0 |
| Performance score | 3 | 4 (better) |
| Health score | 2 | 4 (better) |
| Dividend score | 3 | 5 (better) |
| Valuation | ||
| P/E | 11.6× | 11.3× (better) |
| P/S | – | 15.4× |
| P/B | 1.4× | 1.1× (better) |
| EV/EBITDA | 3.2× (better) | 11.7× |
| P/FCF | 11.5× | 8.0× (better) |
| PEG | 1.40 | – |
| FCF yield | 8.7% | 12.4% (better) |
| Fair value | $39.42 | $37.57 |
| Margin of safety | −7.2% | −1.7% (better) |
| Growth | ||
| Revenue growth (TTM) | – | 2.8% |
| Revenue growth, 5Y average | 6.1% | 10.0% (better) |
| Net income growth (TTM) | 17.2% | 19.0% (better) |
| EPS growth (TTM) | 17.0% | 18.5% (better) |
| EPS growth, 5Y average | 13.2% (better) | 11.6% |
| Profitability | ||
| Operating margin | – | 171% |
| Net margin | – | 136% |
| FCF margin | – | 192% |
| Return on equity | 13.1% (better) | 10.1% |
| Return on invested capital | – | 7.7% |
| Financial health | ||
| Debt / equity | – | 0.57 |
| Net debt / EBITDA | – | 2.65 |
| Altman Z-score | 0.20 | 0.23 (better) |
| Piotroski F-score | 7 (better) | 5 |
| Dividends and buybacks | ||
| Dividend yield | 2.4% | 4.4% (better) |
| Payout ratio | 27.1% | 49.1% |
| Years of dividend growth | 4 | 8 (better) |
| Dividend growth, 5Y average | 5.1% (better) | 3.5% |
| Buyback yield | – | −0.07% |
| Shareholder yield | 2.4% | 4.3% (better) |
| Ownership | ||
| Held by institutions | 46.5% | 66.0% |
| Held by insiders | 16.9% | 3.8% |
| Insider net buying, 12 months | −$1.5M | −$455K (better) |
| Short interest, % of float | 1.5% | 8.4% |
Go deeper
- PEBK stock overview
- PEBK income statement
- PEBK valuation and score
- PEBO stock overview
- PEBO income statement
- PEBO valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.